Serono’s Infertility Treatment Luveris Clears FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Phase IV trial will study the effect of the recombinant luteinizing hormone on time to clinical pregnancy. Luveris is approved for stimulation of follicular development; labeling notes that “a definitive effect on pregnancy” in the targeted population has not been demonstrated.